1-20 of 793
influenza
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TLR8 gain of function: a tall surprise

Bertrand Boisson, Jean-Laurent Casanova
Journal: Blood
Blood (2021) 137 (18): 2420–2422.
https://doi.org/10.1182/blood.2020010463
Published: 2021
Journal Articles

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

Angela Molga, MBBS, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Deepak Singhal, MBBS, MDFRACP, FRCPA, Pratyush Giri, MBBS,FRACP,FRCPA, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5426.
https://doi.org/10.1182/blood-2019-132164
Published: 2019
Journal Articles

Infectious Complications Following Venetoclax-Proteasome Inhibitor Based Regimens in Relapsed Myeloma: A Single Center Retrospective Analysis

Christopher Tor Sauter, MD, Luca L Bernabei, BA, Adam Waxman, MD, Adam D. Cohen, MD, Alfred L. Garfall, MD, Dan T. Vogl, MD, Sara Whittington,, RN, MPH, Colleen Harker Erb, CRNP, Patricia Mangan, CRNP, Mary Sanchez, CRNP, Edward A. Stadtmauer, MD FACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 5598.
https://doi.org/10.1182/blood-2019-132087
Published: 2019
Journal Articles

Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS

Brendan Rasor, PharmD, Tyler Dickerson, PharmD, Qiuhong Zhao, MS, Jonathan E Brammer, MD, Karilyn Larkin, MD, Samantha Jaglowski, MDMPH, Alice S. Mims, MD, Sam Penza, MD, Sumithira Vasu, MDMBBS, Sarah A Wall, MD, Basem M. William, MRCP,MD, Ayman Saad, MD, Julianna Roddy, PharmD, Hannah K. Choe, MD, Marcin Puto, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5715.
https://doi.org/10.1182/blood-2019-123657
Published: 2019
Journal Articles

Cytokine Release Syndrome As a Rare Complication of Nivolumab: A Case Report

Alexander Slota, MD, Roomana Khan, MD, Akhil Rahman, MD, Eiran A Warner, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5630.
https://doi.org/10.1182/blood-2019-127586
Published: 2019
Journal Articles

Relapsed Follicular Lymphoma and Haploidentical Transplantation Using Double Source of Hematopoietic Stem Cells and Post-Transplant Cyclophosphamide: Case Report

Ana Rojas Fonseca, Nelson Hamerschlak, MD PhD, José Salvador Rodrigues de Oliveira, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5718.
https://doi.org/10.1182/blood-2019-125208
Published: 2019
Journal Articles

Outcomes of Patients with T-Lymphoblastic Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single Center

Amandeep Salhotra, MD, Liana Nikolaenko, MD, Lu Chen, PhD, Ni-Chun Tsai, PhD, Diane Lynne Smith, PhD, Auayporn P. Nademanee, MDBS, Leslie L. Popplewell, MD FRCPA, Alex F. Herrera, MD, Matthew Mei, MD, Ibrahim Aldoss, MD, Vinod A. Pullarkat, MD, Stephen J. Forman, MD, Jasmine M. Zain, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5729.
https://doi.org/10.1182/blood-2019-131437
Published: 2019
Journal Articles

Non-Myeloablative Allogeneic Stem Cell Transplant in Acute Myeloid Leukemia: Graft-Versus-Host Disease Potentiates Graft-Versus-Leukemia Effect and Improves Overall Survival

Christopher J Pizzola, MD MPH, Kevin L Rakszawski, MD, W. Christopher Ehmann, MD, Witold B. Rybka, MD, Baldeep Wirk, MD, Seema Naik, MD, Hong Zheng, MD PhD, Brook Silar, Gina Mackey, CCRP, Shin Mineishi, MD, Kentaro Minagawa, MD PhD, David F. Claxton, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5724.
https://doi.org/10.1182/blood-2019-128817
Published: 2019
Journal Articles

Use of Pegylated Interferon in Six Pediatric Patients with Myeloproliferative Neoplasms

Nicole Kucine, MD, Shayla Bergmann, MD, Spencer Krichevsky, BS, Devin Jones, MS, Michael E. Rytting, MD, Linda Resar, MD, John Mascarenhas, MD, Srdan Verstovsek, MD PhD, Ronald Hoffman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4194.
https://doi.org/10.1182/blood-2019-124023
Published: 2019
Journal Articles

Cellular Kinetics and Anti-Therapeutic Antibody in Relapsed/Refractory B-NHL Patients Treated with JWCAR029

Zhitao Ying, MD PhD, Pengpeng Xu, MD, Ming Hao, PhD, Li Wang, MD PhD, Shu Cheng, MD PhD, Wen Wu, MD PhD, Wen Wang, MD PhD, Zisong Zhou, Su Yang, Jennifer Wang, PhD, Harry Lam, PhD, James Li, Hongxia Zheng, MD PhD, Weili Zhao, MD PhD, Yuqin Song, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4083.
https://doi.org/10.1182/blood-2019-126408
Published: 2019
Journal Articles

Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Relapse-Free and Overall Survival

Dipenkumar Modi, MD, Vijendra Singh, MD, Seongho Kim, PhD, Abhinav Deol, MD, Asif Alavi, MD, Lois Ayash, MD, Andrew Kin, MD, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4488.
https://doi.org/10.1182/blood-2019-125418
Published: 2019
Journal Articles

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Joshua A Fein, MD, Avichai Shimoni, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Guy Chowers, MD, Zachary Cohen, Arnon Nagler, MD MSc, Roni Shouval
Journal: Blood
Blood (2019) 134 (Supplement_1): 4489.
https://doi.org/10.1182/blood-2019-126325
Published: 2019
Journal Articles

Correlation of Bridging and Lymphodepleting Chemotherapy with Clinical Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Tisagenlecleucel

Charalambos Andreadis, MD MSCE, Constantine S. Tam, MBBS, MD, Peter Borchmann, MD PhD, Ulrich Jaeger, MD, Joseph P. McGuirk, DO, Harald Holte, MD PhD, Edmund K. Waller, PhDMD, Samantha Jaglowski, MDMPH, Michael R. Bishop, MD, Stephen Ronan Foley, MD FRCPC, Jason R. Westin, MD, Isabelle Fleury, MD, P Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA), Stephan Mielke, MD, Takanori Teshima, MD, Gilles A. Salles, MD PhD, Stephen J Schuster, MD, Veronika Bachanova, MD PhD, Richard T. Maziarz, MD, Koen Van Besien, MD PhD, Koji Izutsu, MD PhD, John M. Magenau, MD, Nina D. Wagner-Johnston, MD, Koji Kato, MD PhD, Paolo Corradini, Ranjan Tiwari, MSc, Rakesh Awasthi, PhD, Tomasz Lawniczek, MD, Lamis K. Eldjerou, MD, Marie Jose Kersten, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2883.
https://doi.org/10.1182/blood-2019-124492
Published: 2019
Journal Articles

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Kodai Kuriyama, MD PhD, Shigeo Fuji, MD PhD, Noriko Doki, MD PhD, Yuta Katayama, MD PhD, Souichi Shiratori, Yukiyasu Ozawa, MD PhD, Takashi Ashida, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3258.
https://doi.org/10.1182/blood-2019-123926
Published: 2019
Journal Articles

Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center for International Blood & Marrow Transplant Research (CIBMTR) Analysis

Sairah Ahmed, MD, Nilanjan Ghosh, MD PhD, Manoj Khanal, Kwang Woo Ahn, PhD, Carlos Litovich, MPH, Timothy S. Fenske, MD, Mohamed A Kharfan-Dabaja, MDMBA, Anna Sureda, MD PhD, Mehdi Hamadani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3318.
https://doi.org/10.1182/blood-2019-121848
Published: 2019
Journal Articles

Intermediate Vs High Dose Busulfan-Based Conditioning for Allogeneic Cell Transplantation in Patients with Acute Leukemia or Myelodysplastic Syndromes from HLA Matched Related or Unrelated Donors: Achieving the Same with Less

Mohamad Sobh, PharmD, Lothar B. Huebsch, MD, Mitchell Sabloff, MSc,MDFRCPC, Jill Fulcher, MDPhDMRCPI FRCPath(UK), Sultan Altouri, MDFRCPC, Michael Kennah, MD, Elizabeth Drouin, MD, David S. Allan, MD FRCPC, MSc, Harold Atkins, MD, Grace Christou, MD, Pierre Villeneuve, MD PhD, Alexandre P.Blanchard, PhD, Kelsey Maclellan, Ranjeeta Mallick, PhD MSc, BSc, Nicole B. Laferriere, MD PhD, Sathish Gopalakrishnan, MD, Sita D. Bhella, MD, Natasha Kekre, MDFRCPC, Christopher Bredeson, MDFRCPC,MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3263.
https://doi.org/10.1182/blood-2019-122436
Published: 2019
Journal Articles

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma

Lekha Mikkilineni, MD, Elisabet E. Manasanch, MD, Norris Lam, BS, Danielle Vanasse, BS, Jennifer N. Brudno, MD, Irina Maric, MD MSci, Jeremy J. Rose, MS, Maryalice Stetler-Stevenson, MD PhD, Hao-Wei Wang, MD PhD, Constance M. Yuan, MD PhD, David F. Stroncek, MD, Jennifer Mann, CRNP, Micaela Ganadan, BSN, RN, Rashmika Patel, Nathan Trinklein, PhD, Ben Buelow, MD PhD, Ronald E. Gress, MD, James N. Kochenderfer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3230.
https://doi.org/10.1182/blood-2019-129088
Published: 2019
Journal Articles

Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor

Michael R. Grunwald, MD, Mei-Jie Zhang, Hany Elmariah, MDMS, Mariam H Johnson, MPH, Andrew St. Martin, MS, Asad Bashey, MD PhD, Javier Bolanos-Meade, MD, Christopher Bredeson, MDFRCPC,MSc, Edward A Copelan, Biju George, MDDM, Vikas Gupta, MD FRCP, FRCPath, Christopher G. Kanakry, MD, Rohtesh S. Mehta, MD, Minoo Battiwalla, MD, Alberto Mussetti, Ryotaro Nakamura, MD, Taiga Nishihori, MD, Wael Saber, MD MS, Melhem Solh, MD, Benjamin K. Tomlinson, MD, Daniel J. Weisdorf, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3323.
https://doi.org/10.1182/blood-2019-125865
Published: 2019
Journal Articles

A Phase II Trial of Melphalan Based Reduced Intensity Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients with Hematologic Malignancies

Melhem Solh, MD, Scott R. Solomon, MD, Xu Zhang, PhD, H. Kent Holland, MD, Lawrence E Morris, MD, Asad Bashey, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3333.
https://doi.org/10.1182/blood-2019-131608
Published: 2019
Journal Articles

Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4 + T Cells

Natalia M Tijaro-Ovalle, MD, Shuli Li, PhD, Zachariah Defilipp, MD, Ioannis Politikos, MD, Robin M. Joyce, MD, Philippe Armand, MD PhD, Vincent T. Ho, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Edwin P. Alyea, III, MD, David E. Avigan, MD, Jacalyn Rosenblatt, MD, Jami Brown, MS, Steven McAfee, MD, Bimalangshu Dey, MD, Areej El-Jawahri, MD, Thomas Spitzer, MD, Yi-Bin Chen, Robert J. Soiffer, MD, Joseph H. Antin, MD, Karen K. Ballen, MD, Corey S. Cutler, MD MPH, FRCPC, Jerome Ritz, MD, Vassiliki A Boussiotis, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3275.
https://doi.org/10.1182/blood-2019-129154
Published: 2019